Used as an intermediate in the synthesis of pharmaceutical compounds, particularly in the development of kinase inhibitors for targeted cancer therapies. Its structure supports selective binding to specific enzyme active sites, enhancing drug efficacy. Commonly employed in research settings to construct complex molecules requiring chiral piperidine motifs. Also utilized in the preparation of proteolysis-targeting chimeras (PROTACs) due to its ability to link targeting ligands with E3 ligase binders. Suitable for conjugation in bioconjugation strategies and medicinal chemistry optimization.